Sep 11, 2018
Dr. Anish Bhatnagar, CEO of Soleno Therapeutics, discusses Prader-Willi syndrome, a rare genetic disease that among other difficult symptoms, most markedly renders patients perpetually starving because of a dysfunctional neural pathway in the brain. This state, otherwise known as hyperphagia, can bring patients to the brink of severe sickness from overeating despite bring full, or from eating garbage, spoiled food, or sometimes even inedible objects. Anish talks about the hardships that this disease inflicts on its patients and its patients’ loved ones raising them, and about DCCR, the experimental treatment his company is developing to address this significantly unmet need for patients struggling with PWS.
#Prader-Willi #PWS #SolenoTx #SLNO #RareDisease #DCCR